Literature DB >> 10750852

Severe dermographism after topical therapy with diphenylcyclopropenone for alopecia universalis.

N Skrebova1, Y Nameda, H Takiwaki, S Arase.   

Abstract

We describe here a 19-year-old Japanese man with an 11-year history of alopecia universalis, who, after the 1st application of a 0.003% diphenylcyclopropenone (DPCP) solution to the whole scalp, developed acute contact dermatitis at the test site, together with widespread severe dermographism. Every 3 weeks, persistence of the severe urticarial reaction and efficacy of treatment were monitored by constant pressure stimuli in a series of pressure tests, and subsequently evaluated by laser Doppler flowmetry (LDF). Although, on pressure tests, the urticarial response was found to significantly improve after starting treatment, erythematous responses continued to appear for nearly 3 months. The persistent course of these side-effects in our patient strongly suggests that precautions must currently be taken in the therapeutic use of potent sensitizers such as DPCP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10750852     DOI: 10.1034/j.1600-0536.2000.042004212.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  2 in total

Review 1.  Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata.

Authors:  Kun-Wei Lai; Tsen-Fang Tsai
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-22

2.  A retrospective comparative study of the efficacy and safety of two regimens of diphenylcyclopropenone in the treatment of recalcitrant alopecia areata.

Authors:  Tueboon Sriphojanart; Saranya Khunkhet; Poonkiat Suchonwanit
Journal:  Dermatol Reports       Date:  2017-11-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.